Stephen Pyles, MD
Pain Medicine · Ocala, FLNPI 1386638674
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 69.7% of it on its own, with 51 other manufacturers making up the rest. Reporting peaked in 2019 at $40,064 and has fallen 66.7% since, to $13,329 in 2025. Among pain medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 808 payments — averaging $142.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$80K
- Stimwave Technologies Incorporated$16K
- Nevro Corp.$2K
- Medtronic$2K
- Vertos Medical, Inc.$2K
- Vertiflex, Inc.$2K
- plus $10K from 46 others
Across 27 payments — averaging $3506.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$95K
What the payments were for
- Consulting fees$9,5248%
- Speaking & faculty fees$60,62553%
- Travel & lodging$15,94214%
- Food & beverage$26,80223%
- Education$80%
- Gifts$2340%
- Entertainment$2,1512%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPECTRA WAVEWRITER$26,562
- WaveWriter Alpha Prime 16$23,382
- GENERAL - THERAPIES$7,184
- GENERAL PAIN MANAGEMENT$4,726
- SCS FreedonSpinal Cord Stimulator$3,412
- WAVEWRITER ALPHA$3,400
- StimQ Peripheral Nerve StimulatorSystem$3,149
- CLINICAL TRIAL PRODUCT$1,900
- Superion ISS$1,738
- mild Device Kit$1,678
- Senza Spinal Cord Stimulation System$1,494
- StimQ Receiver Stimulator Kit Channel A US w Receiver$1,334
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$1,334
- Freedom 4A Receiver Kit Channel A US w Receiver$1,334
- Freedom 8A Receiver Kit Channel A US w Receiver$1,334
- Seglentis$1,275
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$1,000
- PAINTEQ$806
- INTELLIS$621
- PROCLAIM$600
How this compares
$115,284 in reported general payments places this provider in the 95th percentile of 596 pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,674 | $63,517 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,389 | $47,399 |
| Xtampza ErOxycodone Myristate | 59 | $41,546 |
| OxycontinOxycodone Hcl | 40 | $26,729 |
| Oxycodone Hcl | 1,164 | $16,483 |
| MovantikNaloxegol Oxalate | 20 | $8,093 |
| Morphine Sulfate | 316 | $7,310 |
| Nucynta ErTapentadol Hcl | 12 | $7,254 |
| Tramadol Hcl | 691 | $6,953 |
| Gabapentin | 583 | $6,695 |
| Morphine Sulfate ErMorphine Sulfate | 213 | $5,673 |
| Fentanyl | 64 | $4,693 |
| Methadone Hcl | 198 | $3,254 |
| Ondansetron OdtOndansetron | 45 | $2,691 |
| Baclofen | 217 | $2,616 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er | $640 | $48,80071 claims |
| Redhill Biopharma Inc.Movantik | $28 | $8,09320 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 596 pain medicine providers in Florida.
Other pain medicine in Ocala
- Jeffrey GudinMiami$356K
- Joseph PergolizziNaples$333K
- Ramon Cuevas-TrisanRiviera Beach$220K
- Navdeep JassalLakeland$163K
- Mark-Friedrich HurdleJacksonville$140K
- Rodolfo GariTampa$120K
- Orlando FloreteJacksonville$86K
- Michael GreeneMiddleburg$73K
- Nicholas BremerFernandina Beach$66K
- Melanie RosenblattBoca Raton$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.